Ricordeau P, Weill A, Vallier N, Bourrel R, Fender P, Allemand H
Echelon National du Service Médical de l'Assurance Maladie (CNAMTS), CNAMTS. 66, Avenue du Maine, 75 694 Paris Cedex 14, France.
Diabetes Metab. 2000 Sep;26 Suppl 6:25-38.
The statistical analysis of French HealthCare's database, containing total reimbursements to affiliates and a listing of delivered drug prescriptions in the form of specific drug codes, allowed us to update data of the cost of diabetes. This study, realized during the first trimester of 1999, used the combined databases of 110 local healthcare offices (CPAM) among the 128 existing in metropolitan France. French Social Security spent a total of 31.9 billion francs (4.9 billion euros) in care given to diabetics (or 24,137 francs per patient) comprised by 14.2 francs (2.2 billion euros) for in-hospital care and 17.7 billion francs (2.7 billion euros) for outpatient services. The total expenses for diabetic patients represented 4.7% of French Social Security's overall expenses for all its affiliates. The differential cost of diabetes (the difference, at equivalent ages, between cost generated by diabetic patients and those attributable to the remainder of the affiliated population) was estimated, for the generalized health-care regimen (régime général) in 1998, to be 13.3 billion francs (2.0 billion euros). These figures underscore the need to reinforce prevention and screening for end-organ complications since it is generally admitted that the disease's high cost is essentially related to its complications.
对法国医疗保健数据库的统计分析，该数据库包含向附属机构的总报销金额以及以特定药品代码形式列出的已交付药品处方清单，使我们能够更新糖尿病成本数据。这项于1999年第一季度开展的研究，使用了法国本土128个现有地方医疗保健办公室（CPAM）中110个的综合数据库。法国社会保障体系在糖尿病患者护理方面总共支出了319亿法郎（49亿欧元）（即每位患者24,137法郎），其中住院护理支出142亿法郎（22亿欧元），门诊服务支出177亿法郎（27亿欧元）。糖尿病患者的总支出占法国社会保障体系为所有附属机构支出的总费用的4.7%。1998年，对于通用医疗保健制度（régime général），糖尿病的差异成本（在相同年龄下，糖尿病患者产生的成本与附属人群其余部分产生的成本之间的差异）估计为133亿法郎（20亿欧元）。这些数字凸显了加强对终末器官并发症预防和筛查的必要性，因为人们普遍认为该疾病的高成本主要与其并发症有关。
